Archive for the ‘Resveratrol Policy’ Category
A recent headline in the Wall Street Journal reads, “More Elderly Find They Can’t Afford Not to Work.” According to the article, 1.31.million Americans aged 75 or older are currently working – this is a 25% jump from 2005. This trend is likely to accelerate as there are 77 million baby boomers (those born between 1946 and 1964) living in America currently. As such, according to the Wall Street Journal, the government estimates that 10% of Americans 75 and older will be working by 2018 (up from 7.3% now).
For its part, resveratrol likely could help these oldest working Americans by improving energy levels through increased mitochondria (the powerhouses of the cell), improving heart and endothelial function, and improving mental performance by increasing blood flow to the brain. (Please see Resveratrol.com for more information on these benefits)
It is unfortunate that these difficult economic times are forcing our most revered citizens (those seniors over 75) back into the workforce. Hopefully the seniors who must work will be educated to benefits of resveratrol.
Diabetes and Blood Thinner Drugs Are Responsible for the Majority of Hospital Visits – Enter ResveratrolSunday, December 4th, 2011
A study published in the New England Journal of Medicine shed light on what drugs are responsible for the majority of visits by senior citizens to emergency rooms. Surprisingly, widely used diabetes medications and blood thinners are the primary culprits – not the perceived ‘high risk’ medications such as painkillers.
Specifically, the study revealed that an astounding one third of senior hospital visits are related to the blood thinning medication warfarin (for its part, warfarin use must be monitored very closely as it can otherwise lead to dangerous bleeding. According to the study, bleeding due to warfarin costs the health system “probably hundreds of millions of dollars annually).
Further, injectable insulin (mainly for type one diabetics), diabetes pills (mainly for type two diabetics), and aspirin were responsible for another third of hospital visits.
Moreover, left unchecked, these hospitalizations are expected to grow as people live longer and take an ever increasing number of medications. (As of right now, 40 percent of people 65 and older take 5 to 9 medications, while 18 percent take 10 or more!).
The good news is, because we have identified these drivers for our ever increasing higher health costs, we can now address them. Specifically, not only can we better educate the public about how to safely take and monitor these potentially dangerous drugs, but we can look for alternatives ways to treat people.
For its part, the natural compound resveratrol might (at the least) be a partial answer to these hospitalizations (and their accompanying costs – both in human and monetary terms).
Specifically resveratrol has been shown to:
· 1) increase insulin sensitivity in people with type two diabetes and pre-diabetes; and,
· 2) prevent blood platelet aggregation (acting as a blood thinner, thereby helping to prevent strokes and heart attacks).
What makes resveratrol different than many of the above mentioned pharmaceutical drugs is that it is a natural substance with little known negative side effects. So, theoretically, one multi-tasking pill (Resveratrol) (not 5 to 10 pills!) could be given to seniors to help them control their blood sugar and prevent heart attacks and strokes – without the negative side effects and resulting hospital visits.
In this way resveratrol can help to control exploding health care costs plaguing the United States, and increasingly the world.
Science is rapidly discovering indications of Resveratrol’s ability to extend the healthy lifespan of numerous organisms – from yeast, to monkeys, to humans. Resveratrol has been proven to have anti cancer, anti inflammatory, anti diabetic, anti heart disease, anti stroke, and anti Alzheimer’s disease properties. It goes without saying that all of these diseases significantly contribute to healthcare costs in the United States and the world.
For their part, Medicare and Medicaid accounted for a whopping 23% of the US federal budget in 2010 (i.e. 790 billion dollars). And with increasing numbers of baby bombers becoming eligible for these programs (coupled with increasing healthcare costs), this percentage, and dollar figure, will only swell with time.
Part of President Obama’s $4 trillion deficit reduction proposal is to increase the eligibility age of Medicare from 65 to 67 over the next 30 years. On its face, this increase seems entirely reasonable – especially considering steadily increasing American life spans over the last 100 years. And, if widespread resveratrol consumption was thrown into the mix, this increase could easily be higher.
It is likely that humans taking resveratrol would not only live longer, but they would live longer with more energy and mental focus (resveratrol has been shown to increase endurance and blood flow to the brain). In short, they would remain more economically productive in their later years.
Applied to the US budget deficit, longer and more productive lives justify increasing the eligibility age of Medicare – perhaps significantly more than the proposed 2 years over the next 30 years. Further, a healthier population justifies increasing the age of social security eligibility (in 2010, Social Security represented whopping 20% of 2010 US budget - i.e. $700 billion).
In conclusion, it very well may be in the US government’s interest to promote (and in fact accelerate) human resveratrol trials – not only because increased resveratrol consumption may be in the best interest of the health of its citizens, but because it could help the nation out of its financial mess.